{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:04:23Z","timestamp":1793945063455,"version":"4.8.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Optimizing the immunosuppressive regimen is essential to improve the long-term outcomes of pediatric liver transplant recipients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We conducted a prospective, randomized, open-label study to compare the safety and efficacy of 2 treatment approaches during pediatric liver transplantation: tacrolimus monotherapy following basiliximab induction (the study group) and a dual regimen of tacrolimus plus steroids (the control group). A total of 150 patients were enrolled, with 75 patients allocated to each group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>In both groups, recipients achieved graft and recipient overall survival rates exceeding 93%, with no statistically significant differences between them. However, the study group exhibited a significantly lower incidence of acute cellular rejection (ACR), delayed occurrence of ACR, and an improved ACR-free survival rate at 2 y compared with the control group. Notably, the study group also showed a significant reduction in the incidence of de novo donor-specific antibodies at 3-mo and 2-y posttransplant. Furthermore, 6 mo after the transplant, the study group demonstrated significant improvements in weight-for-age <jats:italic toggle=\"yes\">Z<\/jats:italic> score and height-for-age <jats:italic toggle=\"yes\">Z<\/jats:italic> score. No notable differences were observed in postoperative complications or the incidence of liver fibrosis between the 2 groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Basiliximab induction combine with tacrolimus (TAC) monotherapy is a safe and effective immunosuppressive regimen to reduce the episodes of ACR without influencing the development of liver fibrosis and graft and recipient survival rate after pediatric liver transplantation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004951","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T05:01:06Z","timestamp":1709182866000},"page":"1769-1775","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Basiliximab Induction and Postoperative Steroid-free Immunosuppression With Tacrolimus in Pediatric Liver Transplantation: A Randomized Clinical Trial"],"prefix":"10.1097","volume":"108","author":[{"given":"Chong","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuolun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enbo","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Transplantation, Tianjin First Central Hospital, Tianjin, China."},{"name":"Tianjin Key Laboratory for Organ Transplantation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.ajt.2023.02.006","article-title":"OPTN\/SRTR 2021 Annual Data Report: liver.","volume":"23","author":"Kwong","year":"2023","journal-title":"Am J Transplant"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ajt.14489","article-title":"Living donor liver transplantation for biliary atresia: an analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society.","volume":"18","author":"Kasahara","year":"2018","journal-title":"Am J Transplant"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/hep.32223","article-title":"European Liver Transplant Registry: donor and transplant surgery aspects of 16,641 liver transplantations in children.","volume":"75","author":"de Ville de Goyet","year":"2022","journal-title":"Hepatology"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5500\/wjt.v11.i11.443","article-title":"Current status of glucocorticoid usage in solid organ transplantation.","volume":"11","author":"Dashti-Khavidaki","year":"2021","journal-title":"World J Transplant"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1111\/ajt.15513","article-title":"The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes.","volume":"19","author":"Bittermann","year":"2019","journal-title":"Am J Transplant"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/j.1600-6143.2006.01406.x","article-title":"Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression.","volume":"6","author":"Spada","year":"2006","journal-title":"Am J Transplant"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/TP.0b013e318186b8a3","article-title":"Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial.","volume":"86","author":"Lupo","year":"2008","journal-title":"Transplantation"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/TP.0b013e3181ff8794","article-title":"Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trial.","volume":"90","author":"Weiler","year":"2010","journal-title":"Transplantation"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/lt.25813","article-title":"Prophylactic strategy against de novo hepatitis B virus infection for pediatric recipients who receive hepatitis B core antibody-positive liver grafts.","volume":"27","author":"Song","year":"2021","journal-title":"Liver Transpl"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.jpedsurg.2020.01.059","article-title":"The management and outcomes of ABO-incompatible pediatric liver transplantation: experience of a single Chinese center.","volume":"55","author":"Sun","year":"2020","journal-title":"J Pediatr Surg"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/j.1600-6143.2012.04210.x","article-title":"Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children.","volume":"12","author":"Venturi","year":"2012","journal-title":"Am J Transplant"},{"key":"R12-20250604","first-page":"76","article-title":"WHO child growth standards based on length\/height, weight and age.","volume":"450","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/ajt.15022","article-title":"Long-term outcomes of transmesenteric portal vein recanalization for the treatment of chronic portal vein thrombosis after pediatric liver transplantation.","volume":"18","author":"Cavalcante","year":"2018","journal-title":"Am J Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/lt.24677","article-title":"Immunosuppression in pediatric liver transplant recipients: unique aspects.","volume":"23","author":"Miloh","year":"2017","journal-title":"Liver Transpl"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1053\/j.gastro.2018.08.023","article-title":"Evidence of chronic allograft injury in liver biopsies from long-term pediatric recipients of liver transplants.","volume":"155","author":"Feng","year":"2018","journal-title":"Gastroenterology"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/lt.24616","article-title":"Late graft hepatitis and fibrosis in pediatric liver allograft recipients: current concepts and future developments.","volume":"22","author":"Kelly","year":"2016","journal-title":"Liver Transpl"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/lt.26218","article-title":"Allograft fibrosis after pediatric liver transplantation: incidence, risk factors, and evolution.","volume":"28","author":"Angelico","year":"2022","journal-title":"Liver Transpl"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/tri.12100","article-title":"Induction immunosuppression in liver transplantation: a review.","volume":"26","author":"Turner","year":"2013","journal-title":"Transpl Int"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"e14614","DOI":"10.1111\/ctr.14614","article-title":"The optimal immunosuppression management to prevent early rejection after liver transplantation: a systematic review of the literature and expert panel recommendations.","volume":"36","author":"De Martin","year":"2022","journal-title":"Clin Transplant"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4254\/wjh.v13.i6.673","article-title":"Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation.","volume":"13","author":"Schotters","year":"2021","journal-title":"World J Hepatol"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/TP.0000000000000220","article-title":"Epitope analysis of HLA-DQ antigens: what does the antibody see?","volume":"98","author":"Tambur","year":"2014","journal-title":"Transplantation"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/petr.12119","article-title":"Liver allograft pathology in healthy pediatric liver transplant recipients.","volume":"17","author":"Briem-Richter","year":"2013","journal-title":"Pediatr Transplant"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/ajt.12740","article-title":"Dynamics of allograft fibrosis in pediatric liver transplantation.","volume":"14","author":"Venturi","year":"2014","journal-title":"Am J Transplant"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/TP.0000000000000795","article-title":"Donor-specific antibody in pediatric liver transplantation-identifying a tree by its fruit.","volume":"99","author":"Shapiro","year":"2015","journal-title":"Transplantation"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/petr.12373","article-title":"Basiliximab treatment for steroid-resistant rejection in pediatric patients following liver transplantation for acute liver failure.","volume":"18","author":"Shigeta","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep4.1602","article-title":"Modeling outcomes in children with biliary atresia with native liver after 2 years of age.","volume":"4","author":"Venkat","year":"2020","journal-title":"Hepatol Commun"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:03:46Z","timestamp":1749060226000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004951","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,29]]}}}